← Leaderboards
Claes Robert Wahlestedt
Scripps Research Institute, The
$16,919,962
Attributed
$21,108,529
Total exposure
17
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2006–25$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,108,529 · 17
By mechanism
R01$14,986,680 · 10
P50$2,462,390 · 1
R56$1,478,559 · 1
R21$1,045,939 · 3
RC2$915,433 · 1
U18$219,528 · 1
Top collaborators
- Markus Alexander Heilig6 shared
- Paul J Kenny6 shared
- Claude-Henry Volmar6 shared
- Luis Miguel Tuesta1 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Marisa Roberto$41,318,569
- Friedbert Weiss$29,892,668
- Vadim Cherezov$11,238,552
- Lars Y Terenius$1,084,863
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposProteinsBrainCellsRegulationGenesMolecularGenetic TranscriptionMediatingTranscriptBehavioralFunctional DisorderPlayEpigenetic ProcessResponseCodeNovel TherapeuticsModificationComplexTranscriptomicsBrain RegionInterestNeuronsUntranslated Rna
Grant awards (58)
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$442,569
R01 · FY2025 · AG · contact PI
Epigenetic modulation of amygdalar circuits that control alcohol compulsivity$409,489
R01 · FY2025 · AA · contact PI
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$458,061
R01 · FY2024 · AG · contact PI
Epigenetic modulation of amygdalar circuits that control alcohol compulsivity$414,283
R01 · FY2024 · AA · contact PI
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$465,894
R01 · FY2023 · AG · contact PI
Epigenetic modulation of amygdalar circuits that control alcohol compulsivity$418,926
R01 · FY2023 · AA · contact PI
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease$486,875
R01 · FY2022 · AG · contact PI
Epigenetic modulation of amygdalar circuits that control alcohol compulsivity$439,987
R01 · FY2022 · AA · contact PI
BRD4 Inhibitor$219,528
U18 · FY2020 · DA · contact PI
Leveraging the Human Non-Coding Transcriptome to Identify Therapeutics for Healthy Aging and Alzheimers Disease$728,812
R56 · FY2019 · AG · contact PI
Epigenetic Signaling Pathways Contributing to Alcohol Dependence$345,375
R01 · FY2019 · AA · contact PI
Leveraging the Human Non-Coding Transcriptome to Identify Therapeutics for Healthy Aging and Alzheimers Disease$749,747
R56 · FY2018 · AG · contact PI
Elucidating the epigenetic role of alcohol dependence in Alzheimer s disease$383,682
R01 · FY2018 · AA · contact PI
Epigenetic Signaling Pathways Contributing to Alcohol Dependence$345,375
R01 · FY2018 · AA · contact PI
Epigenetic Signaling Pathways Contributing to Alcohol Dependence$345,375
R01 · FY2017 · AA · contact PI
Epigenetic Signaling Pathways Contributing to Alcohol Dependence$345,375
R01 · FY2016 · AA · contact PI
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse$336,119
R01 · FY2016 · DA · contact PI
Long noncoding RNAs as Epigenomic Modulators & CSF Biomarkers in Parkinson's Dis$469,697
P50 · FY2015 · NS · contact PI
Epigenetic Signaling Pathways Contributing to Alcohol Dependence$345,375
R01 · FY2015 · AA · contact PI
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse$334,422
R01 · FY2015 · DA · contact PI
Long noncoding RNAs and chromatin regulation in cocaine addiction$188,996
R21 · FY2015 · DA · contact PI
Long noncoding RNAs as Epigenomic Modulators & CSF Biomarkers in Parkinson's Dis$500,421
P50 · FY2014 · NS · contact PI
Comprehensive analysis of the FMR1 locus transcriptional landscape$378,675
R01 · FY2014 · MH · contact PI
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse$339,516
R01 · FY2014 · DA · contact PI
Antisense RNA Mediated Epigenetic Regulation of Brain Derived Neurotrophic Factor$331,341
R01 · FY2014 · NS · contact PI
Long noncoding RNAs and chromatin regulation in cocaine addiction$191,875
R21 · FY2014 · DA · contact PI
Long noncoding RNAs as Epigenomic Modulators & CSF Biomarkers in Parkinson's Dis$496,417
P50 · FY2013 · NS · contact PI
Comprehensive analysis of the FMR1 locus transcriptional landscape$363,528
R01 · FY2013 · MH · contact PI
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse$336,218
R01 · FY2013 · DA · contact PI
Long noncoding RNAs as Epigenomic Modulators & CSF Biomarkers in Parkinson's Dis$485,533
P50 · FY2012 · NS · contact PI
Small Molecule Identification for the Nociceptin Receptor to Treat Cocaine Abuse$359,406
R01 · FY2012 · DA · contact PI
Comprehensive analysis of the FMR1 locus transcriptional landscape$346,324
R01 · FY2012 · MH · contact PI
Role of noncoding RNAs in schizophrenia$340,808
R01 · FY2012 · MH · contact PI
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease$327,994
R01 · FY2012 · NS · contact PI
Long noncoding RNAs as Epigenomic Modulators & CSF Biomarkers in Parkinson's Dis$510,322
P50 · FY2011 · NS · contact PI
Role of noncoding RNAs in schizophrenia$340,808
R01 · FY2011 · MH · contact PI
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease$325,244
R01 · FY2011 · NS · contact PI
Comprehensive analysis of the FMR1 locus transcriptional landscape$293,816
R01 · FY2011 · MH · contact PI
Comprehensive analysis of the FMR1 locus transcriptional landscape$151,684
R01 · FY2011 · MH · contact PI
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease$91,714
R01 · FY2011 · NS · contact PI
Comprehensive analysis of the FMR1 locus transcriptional landscape$486,250
R01 · FY2010 · MH · contact PI
Noncoding RNAs as epigenomic modulators in Alzheimer's Disease$437,889
RC2 · FY2010 · AG · contact PI
Role of noncoding RNAs in schizophrenia$429,525
R01 · FY2010 · MH · contact PI
Role of MicroRNAs in the Mechanisms of Drug Dependence$425,230
R01 · FY2010 · DA
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease$421,215
R01 · FY2010 · NS · contact PI
Noncoding RNAs as epigenomic modulators in Alzheimer's Disease$4,703
RC2 · FY2010 · AG · contact PI
Discovery and development of nociceptin receptor ligands in alcohol dependence$484,358
R01 · FY2009 · AA · contact PI
Noncoding RNAs as epigenomic modulators in Alzheimer's Disease$472,841
RC2 · FY2009 · AG · contact PI
Role of noncoding RNAs in schizophrenia$429,525
R01 · FY2009 · MH · contact PI
Role of MicroRNAs in the Mechanisms of Drug Dependence$429,525
R01 · FY2009 · DA
Regulatory RNAs as mediators and biomarkers in Alzheimer's Disease$425,469
R01 · FY2009 · NS · contact PI
Role of noncoding RNAs in schizophrenia$429,525
R01 · FY2008 · MH · contact PI
Role of MicroRNAs in the Mechanisms of Drug Dependence$381,800
R01 · FY2008 · DA
RNAi strategy for prolonged inhibition of BACE1: Role for noncoding RNA$180,240
R21 · FY2008 · AG · contact PI
Assay Development Relating to the HTS of the Neuropeptide Y-Y2 Receptor$47,725
R21 · FY2008 · NS · contact PI
RNAi strategy for prolonged inhibition of BACE1: Role for noncoding RNA$220,703
R21 · FY2007 · AG · contact PI
Assay Development Relating to the HTS of the Neuropeptide Y-Y2 Receptor$43,275
R21 · FY2007 · NS · contact PI
Assay Development Relating to the HTS of the Neuropeptide Y-Y2 Receptor$173,125
R21 · FY2006 · NS · contact PI